A Comparison of Urine Dilution Ability between Adult Dominant Polycystic Kidney Disease, Other Chronic Kidney Diseases, and Healthy Control Subjects: A Case-Control Study

Table 1

Baseline demographics of the participants in the study.

	ADPKD patients	Non-ADPKD	Controls
Number of subjects (n)	18	16	18
Age (years)	55 ± 13	56 ± 17	55 ± 15
Gender (men/women)	9/9	9/7	8/10
Office systolic bBP (mmHg)	137 ± 16	130 ± 16	125 ± 10
Office diastolic bBP (mmHg)	79 ± 10	72 ± 9	74 ± 7
eGFR (ml/min/17.3 m^2)	69 ± 27	63 ± 33	87 ± 13
p-Creatinine (µmol/l)	107 ± 44	124 ± 57	76 ± 11
u-Albumin (mg/l)	17 [8; 50]	81 [26; 283]	8 [3, 11]

Patients with adult dominant polycystic kidney disease (ADPKD), patients with non-ADPKD kidney disease (non-ADPKD), and healthy control subjects (controls). Values represent n in either group or mean ± SD or median with 25% and 75% percentiles in brackets. between ADPKD or non-ADPKD patients and healthy controls. ^# between ADPKD and non-ADPKD patients. ADPKD = patients with adult dominant polycystic kidney disease; non-ADPKD = patients with non-ADPKD kidney disease; controls = healthy control subjects. bBP = brachial blood pressure; eGFR = estimated glomerular filtration rate.